Abbvie
ABBV
Abbvie (ABBV) analyst forecast and price target
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Guggenheim | Maintained | Buy | $288.00 | Oct 9, 2026 |
| UBS | Maintained | Neutral | $275.00 from $260.00 | Oct 9, 2026 |
| Cantor Fitzgerald | Maintained | Overweight | $290.00 from $285.00 | Oct 8, 2026 |
| JP Morgan | Maintained | Overweight | $300.00 from $285.00 | Oct 8, 2026 |
| Morgan Stanley | Maintained | Overweight | $310.00 from $296.00 | Oct 7, 2026 |
| Scotiabank | Maintained | Sector Outperform | $320.00 from $280.00 | Oct 6, 2026 |
| HSBC | Maintained | Buy | $315.00 from $300.00 | Sep 10, 2026 |
| Piper Sandler | Maintained | Overweight | $303.00 from $298.00 | Aug 20, 2026 |
| Wells Fargo | Maintained | Overweight | $300.00 from $295.00 | Aug 17, 2026 |
| Wolfe Research | Upgraded | Peer Perform → Outperform | $300.00 | Aug 13, 2026 |
| BNP Paribas | Maintained | Neutral | $247.00 from $218.00 | Aug 11, 2026 |
| Evercore ISI Group | Maintained | Outperform | $260.00 from $246.00 | Aug 10, 2026 |
| Guggenheim | Maintained | Buy | $288.00 from $261.00 | Aug 4, 2026 |
| Cantor Fitzgerald | Maintained | Overweight | $285.00 from $265.00 | Aug 3, 2026 |
| Canaccord Genuity | Maintained | Buy | $290.00 from $282.00 | Aug 3, 2026 |
| Barclays | Maintained | Overweight | $300.00 from $275.00 | Jul 29, 2026 |
| Canaccord Genuity | Maintained | Buy | $282.00 from $273.00 | Jul 22, 2026 |
| Citigroup | Maintained | Neutral | $260.00 from $230.00 | Jul 15, 2026 |
| BMO Capital | Maintained | Outperform | $300.00 from $258.00 | Jul 13, 2026 |
| UBS | Maintained | Neutral | $260.00 from $230.00 | Jul 13, 2026 |
Frequently asked questions
What is the latest analyst rating on ABBV?
On Oct 9, 2026, Guggenheim maintained Abbvie at Buy with a price target of $288.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.